Our lawyers took part in a webinar on digital replicas (i.e., computerized copies of people or objects), organized by ITECH LAW association. During the webinar the panelists provided cross-border insight on this ecosystem as it relates to: (i) helping clients to protect their personality, image and likeness by managing authorized digital replicas and addressing unauthorized digital replicas (or deepfakes) during their lifetime; (ii) helping clients with estates that include digital replicas or that include wishes about digital memorialization; and (iii) the frauds and scams involving digital replicas targeting lawyers, firms and clients.
Directive 2019/790 on copyright and related rights in the Digital Single Market and amending Directives 96/9/EC and 2001/29/EC
The intersection of copyright and AI is a rapidly evolving area with significant implications for creators and consumers alike. With a digital twin, you can simulate the behavior of real-world objects under different conditions, allowing you to better understand how they function and optimize their performance. As digital twin technology evolves and is used across industries, it becomes increasingly important to analyze the legal landscape surrounding its use. It’s essential to find a balance that promotes innovation while protecting individual rights and creative integrity.
Parallel import of medicinal products is an institution that has its source in the EU law, resulting from the free movement of goods (Articles 34-36 TFEU), consisting in importing medicinal products from the European Union countries or a Member State of the European Free Trade Agreement. According to Article 21a of the Pharmaceutical Law, the medicinal products subject to parallel import must have “the same active substance or the same combination of active substances, at least the same indications up to level 3 of the ATC/ ATCvet code […], the same strength, the same route of administration and the same form as a medicinal product authorized for marketing in the territory of the Republic of Poland or a similar form that does not cause therapeutic differences in relation to a medicinal product authorized for marketing in the territory of the Republic of Poland.”[1]
The need for doctors to use a medicinal product not approved for marketing in Poland raises the question of whether the lack of registration of the drug in Poland is equivalent to a ban on its use.
The solution to this problem can be found in Article 45 paragraph 3 of the Act of 5 December 1996 on the professions of physician and dentist (Journal of Laws of 2024, item 1287), which indicates that in justified cases, a physician may prescribe medicines admitted to trading in other countries, with a detailed justification in the medical documentation.
Our lawyers took part in the training “Fighting fraud – how a digital identifier increases the security of financial services”, organized by the techUK association. The event was attended by specialists from various areas of financial technology, including Elis Thomas from TechUK, Chris Lewis from Synectics Solutions, Laura Barrowcliff from GBG Plc, Adrian Field from OneID Mand Adam Gagen from Revolut.
Technology is changing the face of the financial sector by introducing innovative solutions such as open banking, digital assets and new forms of payment, which makes financial services faster and more accessible. Nevertheless, technological developments go hand in hand with the increasing number of sophisticated online scams. According to research by Synectics Solutions, in the first half of last year, nearly 600 million pounds of fraud was stolen in the UK, most of which were identity fraud. Forecasts indicate that by 2025, this type of fraud may account for up to half of all bank fraud. In the digital world, effective identity verification is key to fraud prevention, and a digital identifier is becoming an indispensable tool in the fight against these threats. Its widespread use can significantly increase the security of online financial services. However, in order to effectively counter fraud, cross-sectoral cooperation is needed, covering both the financial sector and the technology industry.
